Clin2
NCT06071208Likely a fitNot yet recruiting

Preventing kidney disease in Egyptians with diabetes

Diabetes Mellitus Without Complication

Part of Hormones & metabolism, Kidney & urinary clinical trials.

This study is for people with diabetes or prediabetes (higher-than-normal blood sugar) and aims to help prevent kidney damage. It may help you keep your kidneys healthy.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have diabetes or prediabetes
  • You are willing to participate in a study to prevent kidney problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06398977Recruiting
Dapagliflozin to protect kidney function in dialysis patients

This trial tests whether a diabetes drug called dapagliflozin can help people on peritoneal dialysis keep their remaining kidney function longer. It is for patients who started dialysis recently and still make urine.

Chengdu, Sichuan
NCT06147232Not yet recruiting· Phase 2
Preventing kidney disease progression in type 1 diabetes with a new drug

This study tests whether a daily medication can slow down kidney damage in people with type 1 diabetes who already have some kidney problems. It may help protect your kidneys from getting worse.

Herlev
NCT05345327Recruiting· Phase 3
First diabetes pill to protect kidneys

This Phase 3 trial tests whether starting a diabetes medicine called dapagliflozin can better slow kidney damage than starting metformin in adults with type 2 diabetes. It may help preserve kidney function over time and reduce future kidney decline.

Sydney, New South Wales
NCT05749679Not yet recruiting
Preventing kidney failure in type 2 diabetes

This study looks at ways to slow down kidney damage in people who have had type 2 diabetes for several years. It aims to keep your kidneys working longer and prevent further decline.

NCT07116928Not yet recruiting· Phase 4
Study of ganagliflozin for kidney disease in people with type 2 diabetes

This trial tests whether a medicine called ganagliflozin can slow down kidney damage in people with type 2 diabetes and chronic kidney disease. If you qualify, you may be able to take part in this study to see if it helps protect your kidneys.

Shanghai, Shanghai Municipality
NCT05715814Recruiting· Phase 3
Test diabetes-pill type medicine on kidney dialysis safety

This Phase 3 trial studies the safety of an SGLT2 inhibitor (a diabetes medication that can affect kidney fluid handling) in people on peritoneal dialysis. The goal is to see how the treatment works in your type of dialysis and whether it causes any problems.

Toronto, Ontario

Hear when a new Diabetes Mellitus Without Complication trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.